PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities

NCT01325688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Superficial Basal Cell Carcinoma

Interventions

DRUG: PEP005 (ingenol mebutate) Gel, 0.05%
DEVICE: Aluminium disk
DEVICE: OpSite(TM) disk

Sponsor

Peplin